Diaminoalkanes of Formula I have now been found which are orally active and bind to aspartic proteases to inhibit their activity. They are useful in the treatment or amelioration of diseases associated with elevated levels of aspartic protease activity. The invention also relates to a method for the use of the compounds of Formula I in ameliorating or treating aspartic protease related disorders in a subject in need thereof comprising administering to said subject an effective amount of a compound of Formula I.
公式I的二
氨基烷已被发现具有口服活性并能结合
天冬氨酸蛋白酶以抑制其活性。它们可用于治疗或改善与
天冬氨酸蛋白酶活性升高相关的疾病。本发明还涉及一种使用公式I化合物改善或治疗需要的
天冬氨酸蛋白酶相关疾病的方法,包括向该受试者施用有效量的公式I化合物。